Cerebrospinal fluid metabolites and their association with female reproductive disorders: Insights from Mendelian randomization

Yining Zhou, Xiaoqiang Wang, Ziqiang Ding, Ya Wang, Weiwei SongResearch Square 2024 · DOI

TL;DR

This study utilizes Mendelian randomization to identify a causal link between specific metabolites in the cerebrospinal fluid (CSF) and common female reproductive disorders, such as polycystic ovary syndrome (PCOS) and infertility. By analyzing genetic data, the researchers pinpointed several metabolic "protectors" and "risk factors," offering a new neuro-metabolic perspective on diagnosing and treating reproductive health issues.

What Problem Does This Paper Address?

While the link between the brain and reproductive organs—the hypothalamus-pituitary-gonadal (HPG) axis—is well-established, we still lack a granular understanding of how brain-specific metabolic environments influence ovarian health. Most research focuses on blood-based biomarkers, but the cerebrospinal fluid (CSF) provides a more direct window into the central nervous system's regulatory state.

The challenge in this field is distinguishing between correlation and causation. Do metabolic changes cause reproductive disorders, or are they merely a byproduct? Traditional observational studies often struggle with "reverse causality" and environmental confounding factors. This paper addresses these gaps by investigating whether the metabolic profile of the CSF plays a causal role in the development of ovarian diseases and infertility.

Methods

The researchers employed Two-Sample Mendelian Randomization (MR). Think of MR as nature’s version of a randomized controlled trial. It uses genetic variants (Single Nucleotide Polymorphisms, or SNPs) that are randomly assigned at conception as "instrumental variables" to represent the exposure (CSF metabolites). Because these genetic markers are fixed, they aren't influenced by the disease state, helping to isolate a true causal effect.

Key technical aspects include:

  • Inverse-Variance Weighted (IVW) Method: Used as the primary statistical engine to estimate the causal effect.
  • Sensitivity Analyses: The team used MR-Egger, weighted median, and MR-PRESSO to detect and correct for "pleiotropy"—a situation where a genetic variant affects the outcome through pathways other than the metabolite being studied.
  • Reverse MR: Conducted to ensure that the ovarian diseases weren't actually the cause of the changes in CSF metabolites.

Datasets

The study integrated large-scale genomic data from two primary sources:

  1. Exposure Data: 339 GWAS (Genome-Wide Association Study) datasets pertaining to CSF metabolites, originally compiled by Daniel J. Panyard and available via the GWAS Catalog. This included data on over 17 million valid SNPs.
  2. Outcome Data: Statistics on four ovarian diseases (PCOS, ovarian insufficiency, benign tumors, and salpingitis) and female infertility were sourced from the FinnGen database, a massive repository of genetic and health data from the European population.

Key Insights and Ideas

  • The Neuro-Reproductive Bridge: The findings reinforce the idea that the brain's chemical environment is intimately tied to ovarian function. CSF is not just "brain padding"; its metabolic fluctuations can be precursors to peripheral reproductive issues.
  • Metabolic Protectors: Several metabolites were identified as significantly reducing the risk of disease. For instance, serine and taurine were linked to a lower risk of PCOS, while histidine showed a remarkably strong protective effect against benign ovarian tumors (OR = 0.1735).
  • Infertility Inhibitors: The study highlighted lactate and glycerophosphoinositol (GroPIns) as potential inhibitors of infertility. The authors hypothesize that these substances contribute to a healthy, anti-inflammatory environment conducive to conception.
  • Unidirectional Causality: Perhaps most importantly, the reverse MR analysis showed no evidence that ovarian diseases cause changes in CSF metabolites, suggesting that the metabolic shifts likely precede the clinical onset of the disorders.

Key Results

The study identified specific metabolic signatures for different conditions:

  • PCOS: Serine (OR = 0.8286) and taurine (OR = 0.8822) reduced risk, while pseudouridine and N-acetylserine increased it.
  • Ovarian Insufficiency (POI): O-sulfo-L-tyrosine and N-acetylglutamate were associated with reduced occurrence.
  • Benign Ovarian Tumors (BET): 15 metabolites were linked to BET. Notably, X-23590 (OR = 0.114) and histidine (OR = 0.1735) were associated with a significantly lower risk.
  • Infertility: Lactate and GroPIns were confirmed as protective factors against infertility across multiple datasets.

Limitations and Future Work

The authors acknowledge several hurdles:

  • Population Specificity: The data is derived almost exclusively from European populations. Genetic differences between ethnicities mean these results might not be directly applicable to other geographic groups.
  • Sample Size Constraints: CSF is a "rare" source compared to blood or urine, which limits the sample size of the exposure data and may introduce some bias.
  • The "How" remains a Mystery: While MR establishes that a causal link exists, it doesn't fully explain the biological mechanism. Future research will need to move from statistical models to functional laboratory studies to understand exactly how these metabolites interact with the HPG axis to influence ovarian health.

Summary updated

Abstract

<title>Abstract</title> Background Recently, the fertility rate has been declining. This is because of a drop in the desire for fertility among young people and the incidence of various degrees of reproductive dysfunction. Theories of 'kidney-generating marrow' and 'kidney-governing reproduction' exist in traditional Chinese medicine, and modern science has confirmed the existence of the 'hypothalamus-pituitary-gonadal axis' as a regulatory mechanism. Cerebrospinal fluid (CSF), a naturally occurring fluid in the brain, has the potential to reflect the physiological and pathological states of the brain. Furthermore, its metabolites may play a crucial role in the early detection of ovarian diseases. In this study, the Mendelian randomization (MR) method was used to investigate the potential influence of CSF metabolites on four prevalent ovarian diseases affecting women of childbearing age and their relationship with female infertility. This analysis aimed to elucidate the underlying mechanisms, thereby providing a foundation for future research. Method The most recent genome-wide association study was used to synthesize the statistical data, and a comprehensive two-sample MR analysis was used to assess the causal relationship between 399 CSF metabolites and four ovarian-related diseases (including polycystic ovary syndrome (PCOS), ovarian insufficiency, benign ovarian tumors, and salpingitis), as well as female infertility. The two-sample MR analysis was conducted using the inverse-variance weighted method as the primary approach and complemented by pleiotropic and heterogeneity tests. To ensure the reliability of the findings, a leave-one-out sensitivity analysis was performed. Finally, the robustness of the results was validated through a reverse MR analysis. Results Following a comprehensive and systematic analysis, it was determined that PCOS was associated with four distinct metabolites, including serine. Similarly, ovarian insufficiency was linked to four metabolites, including O-sulfo-L-tyrosine. Additionally, benign ovarian tumors were associated with 15 metabolites. The levels of X-23590 (odds ratio [OR] = 0.114) and histidine (OR = 0.1735) were significantly associated with a reduced occurrence of benign ovarian tumors. While ovarian-related inflammation was associated with five metabolites, including lactate, comparative analysis confirmed that lactate and glycerophosphoinositol levels can inhibit the occurrence of infertility. All diseases exhibited no reverse relationship with CSF metabolites. Conclusion A comprehensive exploration of the causal relationship between CSF metabolites and common ovarian diseases, as well as infertility in women of childbearing age, may enhance our understanding of their potential impact on female reproductive health. This may provide new ideas for diagnosing and treating female reproductive health.
BibTeX
@inproceedings{zhou2024cerebrospinal,
  author = {Yining Zhou and Xiaoqiang Wang and Ziqiang Ding and Ya Wang and Weiwei Song},
  title = {{Cerebrospinal fluid metabolites and their association with female reproductive disorders: Insights from Mendelian randomization}},
  booktitle = {Research Square},
  year = {2024},
  doi = {10.21203/rs.3.rs-5344014/v1},
}
Figure